EGFR c.2258C>A ;(p.P753Q)

Variant ID: 7-55242488-C-A

NM_005228.3(EGFR):c.2258C>A;(p.P753Q)

This variant was identified in 11 publications

View GRCh38 version.




Publications:


Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma.

Frontiers In Oncology
Ye, Ke K; Fan, Qinqiao Q; Yuan, Mingming M; Wang, Dong D; Xiao, Liang L; Long, Guo G; Chen, Rongrong R; Fang, Tongdi T; Li, Zengbo Z; Zhou, Ledu L
Publication Date: 2022

Variant appearance in text: EGFR: 2258C>A; P753Q
PubMed Link: 35311090
Variant Present in the following documents:
  • Table_1.xlsx, sheet 3
View BVdb publication page



Ultrasensitive analysis of genetic instability related to chemical exposure.

Journal Of Applied Genetics
Domoradzki, Tomasz T; Grochowski, Piotr P; Jaśkiewicz, Anna A; Pająk, Beata B
Publication Date: 2022-05

Variant appearance in text: EGFR: P753Q
PubMed Link: 34967917
Variant Present in the following documents:
  • Main text
  • 13353_2021_Article_677.pdf
View BVdb publication page



Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.

Frontiers In Immunology
Li, Na N; Wang, Jiahong J; Zhan, Xianquan X
Publication Date: 2021

Variant appearance in text: EGFR: 2258C>A; P753Q
PubMed Link: 34887858
Variant Present in the following documents:
  • Table_3.xlsx, sheet 1
View BVdb publication page



A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Cancer Medicine
Lee, Ji Hyun JH; Heo, Seong Gu SG; Ahn, Beung-Chul BC; Hong, Min Hee MH; Cho, Byoung Chul BC; Lim, Sun Min SM; Kim, Hye Ryun HR
Publication Date: 2021-10

Variant appearance in text: EGFR: P753Q
PubMed Link: 34528763
Variant Present in the following documents:
  • Main text
  • CAM4-10-7012.pdf
View BVdb publication page



A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Cancer Medicine
Lee, Ji Hyun JH; Heo, Seong Gu SG; Ahn, Beung-Chul BC; Hong, Min Hee MH; Cho, Byoung Chul BC; Lim, Sun Min SM; Kim, Hye Ryun HR
Publication Date: 2021-10

Variant appearance in text: EGFR: P753Q
PubMed Link: 34528763
Variant Present in the following documents:
  • Main text
  • CAM4-10-7012.pdf
View BVdb publication page



Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy.

Theranostics
von Baumgarten, Louisa L; Kumbrink, Jörg J; Jung, Andreas A; Reischer, Anna A; Flach, Madeleine M; Liebmann, Sibylle S; Metzeler, Klaus H KH; Holch, Julian W JW; Niyazi, Maximilian M; Thon, Niklas N; Straube, Andreas A; von Bergwelt-Baildon, Michael M; Heinemann, Volker V; Kirchner, Thomas T; Westphalen, Christoph Benedikt CB
Publication Date: 2020

Variant appearance in text: EGFR: P753Q
PubMed Link: 31903155
Variant Present in the following documents:
  • Main text
  • thnov10p0856.pdf
View BVdb publication page



Clinical mutational profiling of 1006 lung cancers by next generation sequencing.

Oncotarget
Illei, Peter B PB; Belchis, Deborah D; Tseng, Li-Hui LH; Nguyen, Doreen D; De Marchi, Federico F; Haley, Lisa L; Riel, Stacy S; Beierl, Katie K; Zheng, Gang G; Brahmer, Julie R JR; Askin, Frederic B FB; Gocke, Christopher D CD; Eshleman, James R JR; Forde, Patrick M PM; Lin, Ming-Tseh MT
Publication Date: 2017-11-14

Variant appearance in text: EGFR: 2258C>A
PubMed Link: 29228562
Variant Present in the following documents:
  • oncotarget-08-96684.pdf
View BVdb publication page



Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and Are Primed for Neoplastic Progression.

Molecular Cancer Research : Mcr
Drew, David A DA; Mo, Allen A; Grady, James J JJ; Stevens, Richard G RG; Levine, Joel B JB; Brenner, Bruce M BM; Anderson, Joseph C JC; Forouhar, Faripour F; O'Brien, Michael J MJ; Devers, Thomas J TJ; Rosenberg, Daniel W DW
Publication Date: 2018-03

Variant appearance in text: EGFR: P753Q
PubMed Link: 29222172
Variant Present in the following documents:
  • Main text
View BVdb publication page



Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC.

Ejnmmi Research
Bahce, Idris I; Yaqub, Maqsood M; Errami, Hanane H; Schuit, Robert C RC; Schober, Patrick P; Thunnissen, Erik E; Windhorst, Albert D AD; Lammertsma, Adriaan A AA; Smit, Egbert F EF; Hendrikse, N Harry NH
Publication Date: 2016-12

Variant appearance in text: EGFR: P753Q
PubMed Link: 26857779
Variant Present in the following documents:
  • Main text
View BVdb publication page



Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer.

Oncotarget
Xu, Naiqing N; Fang, Wenfeng W; Mu, Libing L; Tang, Yanna Y; Gao, Lei L; Ren, Shengxiang S; Cao, Dengfeng D; Zhou, Lixin L; Zhang, Aiqun A; Liu, Deruo D; Zhou, Caicun C; Wong, Kwok-Kin KK; Yu, Lei L; Zhang, Li L; Chen, Liang L
Publication Date: 2016-01-26

Variant appearance in text: EGFR: P753Q
PubMed Link: 26646697
Variant Present in the following documents:
  • oncotarget-07-3884-s001.pdf
View BVdb publication page



Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype.

Scientific Reports
Fu, Yong Y; Cruz-Monserrate, Zobeida Z; Helen Lin, H H; Chung, Yiyin Y; Ji, Baoan B; Lin, Szu-Min SM; Vonderfecht, Steven S; Logsdon, Craig D CD; Li, Chien-Feng CF; Ann, David K DK
Publication Date: 2015-08-20

Variant appearance in text: EGFR: P753Q
PubMed Link: 26289340
Variant Present in the following documents:
  • srep13347-s1.pdf
View BVdb publication page



Analysis of cancer mutation signatures in blood by a novel ultra-sensitive assay: monitoring of therapy or recurrence in non-metastatic breast cancer.

Plos One
Chen, Zhenbin Z; Feng, Jinong J; Buzin, Carolyn H CH; Liu, Qiang Q; Weiss, Lawrence L; Kernstine, Kemp K; Somlo, George G; Sommer, Steve S SS
Publication Date: 2009-09-28

Variant appearance in text: EGFR: 2258C>A
PubMed Link: 19789704
Variant Present in the following documents:
  • pone.0007220.s001.xls, sheet 1
View BVdb publication page